Proposal(s)
1.
DIRECTOR
GARY S. JACOB
MELVIN K. SPIGELMAN
JOHN P. BRANCACCIO
THOMAS H. ADAMS
ALAN F. JOSLYN
RICHARD DALY
TIMOTHY S. CALLAHAN
BOARD RECOMMENDATION: For
For All Withhold All Vote Individually
2.
PROPOSAL TO AMEND THE COMPANY'S SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE FROM 350,000,000 TO 400,000,000.
BOARD RECOMMENDATION: For
For Against Abstain
3.
PROPOSAL TO APPROVE THE SYNERGY PHARMACEUTICALS INC. 2017 EQUITY INCENTIVE PLAN.
BOARD RECOMMENDATION: For
For Against Abstain
4.
PROPOSAL TO RATIFY BDO USA, LLP AS SYNERGY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.
BOARD RECOMMENDATION: For
For Against Abstain
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.